A GLP-1 such as Wegovy or Zepbound can be a reasonable option, but being in perimenopause and already on an antidepressant or other psychiatric medication changes what we check before starting and what we monitor afterward
He did this in tandem with Raymond Pederson, his first graduate student and the technical assistance of Jill Dryburgh (Brown)
AOD-9604 offers a gentler approach with more selective fat targeting and fewer systemic effects, making it suitable for individuals who cannot tolerate GLP-1 agonists or prefer a more focused mechanism
Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, and Boyd AE, 3rd
Retrieved from GoodRx-e
We aim to eliminate conflicting information and ensure every clinic is described in a trustworthy, transparent manner